Evidence map›Paper›PMID 29505168›Full record

ArticleInfluenza and other respiratory viruses2018

Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States.

F Scott Dahlgren, David K Shay, Hector S Izurieta, Richard A Forshee, Michael Wernecke, Yoganand Chillarige, Yun Lu, Jeffrey A Kelman, Carrie Reed

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.Drug metabolism and disposition: the biological fate of chemicals · 2020
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

F Scott DahlgrenCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, Atlanta, GA, USA.ORCID 0000-0003-1790-2804
David K ShayCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, Atlanta, GA, USA.ORCID 0000-0001-9619-4820
Hector S IzurietaCenter for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Richard A ForsheeCenter for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Michael WerneckeAcumen LLC., Burlingame, CA, USA.
Yoganand ChillarigeAcumen LLC., Burlingame, CA, USA.
Yun LuCenter for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Jeffrey A KelmanCenters for Medicare and Medicaid Services, Washington, DC, USA.
Carrie ReedCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver 34 million residents of the United States aged 65 years and older are also Medicare prescription drug beneficiaries. Medical claims records for this age group potentially provide a wealth of data for better understanding influenza epidemiology.

objectiveThe purpose of this study was to evaluate data on oseltamivir dispensing extracted from medical claims records as an indicator of influenza activity in the United States for the 2010-11 through 2014-15 influenza seasons.

methodsWe used Centers for Medicare and Medicaid Services (CMS) medical claims data to evaluate the weekly number of therapeutic oseltamivir prescriptions dispensed following a rapid influenza diagnostic test among beneficiaries 65 years old and older as an indicator of influenza timing and intensity. We compared the temporal changes in this indicator to changes in the proportion of influenza-like illnesses among outpatient visits in the US Outpatient Influenza-like Illness Surveillance Network (ILINet) by administrative regions defined by the US Department of Health and Human Services. Using the moving epidemic method, we determined intensity thresholds and categorized the severity of seasons for both CMS and ILINet data.

resultsCenters for Medicare and Medicaid Services oseltamivir data and ILINet data were strongly correlated by administrative region (median Spearman's ρ = 0.78; interquartile range = 0.73-0.80). CMS oseltamivir data and ILINet data substantially agreed (Cohen's weighted κ = 0.62) as to the seasonal severity across administrative regions.

conclusionsOur results support the use of oseltamivir dispensing in medical claims data as an indicator of US influenza activity.

Indexed as

Centers for Medicare and Medicaid Services, U.S.Medical RecordsAgedAntiviral AgentsHumansInfluenza, HumanOseltamivirRetrospective StudiesSeasonsTime FactorsUnited StatesAntiviral AgentsOseltamivirantiviralsinfluenzamedicaresurveillancevalidity

Identifiers

PMID29505168
PMCPMC6005588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.